An IGF-Trap as novel treatment for cancer and metastasis
The present proposal seeks to address an urgent need to evelop new trugs that target metastatic cancer with high efficacy and specificity. The type 1 insulin like growth factor (IGF-I) is a growth-promoting factor implicated in cancer cell growth and metastasis. The receptor for IGF-I has been validated as a target for anticancer therapy in different tumor types. We recently engineered a soluble human IGF-I receptor decoy )sIGFIR) that has already shown anti-metastatic activity in pre-clinical animal models. Presently, the structure of this molecule is being further modified in order to improve its staility and pharmacological efficacy as part of a $875,000 collaborative project supported
mainly by tbe PSVT -3 program of the MDEIE in Quebec. As an important addition to this
project, the trainees will define the mechanism of action of this potential drug, particularly its
effect on cancer-induced and cancer-independent angiogenesis using in vitro and in vivo models. Their findings will…..
Voir la description complète du projetPnina Brodt
MSBi Valorisation
Life Sciences
Finance and Insurance
Research Institute of the McGill University Health Centre
Accelerate